These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

28 related articles for article (PubMed ID: 22446887)

  • 1. Phosphorylated nuclear DICER1 promotes open chromatin state and lineage plasticity of AT2 tumor cells in lung adenocarcinomas.
    Reyes-Castro RA; Chen SY; Seemann J; Kundu ST; Gibbons DL; Arur S
    Sci Adv; 2023 Jul; 9(30):eadf6210. PubMed ID: 37494452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. microRNA-based cancer cell reprogramming technology.
    Nishikawa S; Ishii H; Haraguchi N; Kano Y; Fukusumi T; Ohta K; Ozaki M; Dewi DL; Sakai D; Satoh T; Nagano H; Doki Y; Mori M
    Exp Ther Med; 2012 Jul; 4(1):8-14. PubMed ID: 23060915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNAs Regulating Cytoskeleton Dynamics, Endocytosis, and Cell Motility-A Link Between Neurodegeneration and Cancer?
    Gerasymchuk D; Hubiernatorova A; Domanskyi A
    Front Neurol; 2020; 11():549006. PubMed ID: 33240194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and validation of a RNA binding protein-associated prognostic model for lung adenocarcinoma.
    Li W; Gao LN; Song PP; You CG
    Aging (Albany NY); 2020 Feb; 12(4):3558-3573. PubMed ID: 32087603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-425-5p Expression Affects BRAF/RAS/MAPK Pathways In Colorectal Cancers.
    Angius A; Pira G; Scanu AM; Uva P; Sotgiu G; Saderi L; Manca A; Serra C; Uleri E; Piu C; Caocci M; Ibba G; Zinellu A; Cesaraccio MR; Sanges F; Muroni MR; Dolei A; Cossu-Rocca P; De Miglio MR
    Int J Med Sci; 2019; 16(11):1480-1491. PubMed ID: 31673240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 3'-UTR Polymorphisms in the MiRNA Machinery Genes DROSHA, DICER1, RAN, and XPO5 Are Associated with Colorectal Cancer Risk in a Korean Population.
    Cho SH; Ko JJ; Kim JO; Jeon YJ; Yoo JK; Oh J; Oh D; Kim JW; Kim NK
    PLoS One; 2015; 10(7):e0131125. PubMed ID: 26147304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miRNA biogenesis: biological impact in the development of cancer.
    Romero-Cordoba SL; Salido-Guadarrama I; Rodriguez-Dorantes M; Hidalgo-Miranda A
    Cancer Biol Ther; 2014; 15(11):1444-55. PubMed ID: 25482951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An essential microRNA maturing microprocessor complex component DGCR8 is up-regulated in colorectal carcinomas.
    Kim B; Lee JH; Park JW; Kwon TK; Baek SK; Hwang I; Kim S
    Clin Exp Med; 2014 Aug; 14(3):331-6. PubMed ID: 23775303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct reprogramming 101.
    Takahashi K
    Dev Growth Differ; 2010 Apr; 52(3):319-33. PubMed ID: 20298260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concise review: Oct4 and more: the reprogramming expressway.
    Sterneckert J; Höing S; Schöler HR
    Stem Cells; 2012 Jan; 30(1):15-21. PubMed ID: 22009686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dicer 1, ribonuclease type III modulates a reprogramming effect in colorectal cancer cells.
    Dewi DL; Ishii H; Haraguchi N; Nishikawa S; Kano Y; Fukusumi T; Ozaki M; Saito T; Sakai D; Satoh T; Doki Y; Mori M
    Int J Mol Med; 2012 Jun; 29(6):1060-4. PubMed ID: 22446887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pluripotent reprogramming of fibroblasts by lentiviral mediated insertion of SOX2, C-MYC, and TCL-1A.
    Picanço-Castro V; Russo-Carbolante E; Reis LC; Fraga AM; de Magalhães DA; Orellana MD; Panepucci RA; Pereira LV; Covas DT
    Stem Cells Dev; 2011 Jan; 20(1):169-80. PubMed ID: 20504151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimal reprogramming factor stoichiometry increases colony numbers and affects molecular characteristics of murine induced pluripotent stem cells.
    Tiemann U; Sgodda M; Warlich E; Ballmaier M; Schöler HR; Schambach A; Cantz T
    Cytometry A; 2011 Jun; 79(6):426-35. PubMed ID: 21548079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypoxia and TP53 deficiency for induced pluripotent stem cell-like properties in gastrointestinal cancer.
    Hoshino H; Nagano H; Haraguchi N; Nishikawa S; Tomokuni A; Kano Y; Fukusumi T; Saito T; Ozaki M; Sakai D; Satoh T; Eguchi H; Sekimoto M; Doki Y; Mori M; Ishii H
    Int J Oncol; 2012 May; 40(5):1423-30. PubMed ID: 22293932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term culture following ES-like gene-induced reprogramming elicits an aggressive phenotype in mutated cholangiocellular carcinoma cells.
    Nagai K; Ishii H; Miyoshi N; Hoshino H; Saito T; Sato T; Tomimaru Y; Kobayashi S; Nagano H; Sekimoto M; Doki Y; Mori M
    Biochem Biophys Res Commun; 2010 Apr; 395(2):258-63. PubMed ID: 20381452
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.